USPTO trademark

ADTHYZA (THYROID TABLETS, USP)

RegisteredUSPTOWord and designClass 5

"ADTHYZA (THYROID TABLETS, USP)" is a word and design mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on August 8, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Azurity Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of July 18, 2023Official USPTO record

As filed with the USPTO

Status: Registered; Since July 18, 2023
Filed: August 8, 2022
Registered: July 18, 2023
Expires: Not recorded
Application no.: 97538981
Registration no.: 7116955
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 1 class

Ownership

Who owns ADTHYZA (THYROID TABLETS, USP)

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

Woburn, United States

93 trademarks in the portfolioView company

Representative

Elizabeth Fox

King & Spalding

Goods and services

What the mark covers

The products and services ADTHYZA (THYROID TABLETS, USP) is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for the treatment of hypothyroidism

History

What has happened so far

Steps recorded by the USPTO, newest first.

March 19, 2025Assignment of ownership not updated automatically
July 18, 2023Notice of registration confirmation emailed
July 18, 2023Registered-principal register
June 16, 2023Notice of acceptance of statement of use e-mailed
June 15, 2023Allowed principal register - sou accepted
May 23, 2023Statement of use processing complete
May 22, 2023Case assigned to intent to use paralegal
May 1, 2023Use amendment filed
May 1, 2023Teas statement of use received
April 11, 2023Noa e-mailed - sou required from applicant

8 earlier steps on the official record.

FAQ

About ADTHYZA (THYROID TABLETS, USP)

Who owns the trademark "ADTHYZA (THYROID TABLETS, USP)"?

The USPTO trademark "ADTHYZA (THYROID TABLETS, USP)" (application 97538981) is owned by Azurity Pharmaceuticals, Inc.

What is the status of "ADTHYZA (THYROID TABLETS, USP)"?

Its status at the USPTO is: registered.

When was "ADTHYZA (THYROID TABLETS, USP)" registered?

It was registered on July 18, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ADTHYZA (THYROID TABLETS, USP) and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2ad5-802c-7450-bd9a-2be0f8754583
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2ad5-802c-7450-bd9a-2be0f8754583",
  "object": "trademark",
  "mark_text": "ADTHYZA (THYROID TABLETS, USP)",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97538981",
  "filing_date": "2022-08-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019f286b-d581-7185-9ea7-9064179a9309"
    }
  ]
}